Cephalon's Lollipops of Death: 56 Patients at One Clinic Die of Off-Label Painkiller Use | BNET Pharma Blog | BNET
Links shared publicly online about this topic.
- 1,101total visits
Cephalon's Lollipops of Death: 56 Patients at One Clinic Die of Off-Label Painkiller Use | BNET Pharma Blog | BNET
View full resource at industry.bnet.com
Tags: Pain, Cancer Pain Medication, Drug, Pharma, Actiq, Cephalon, Doctor
Most Recently Shared on June 12, 2010 at 3:05 pm By:
Cephalon's Lollipops of Death: 56 Patients at One Pain Clinic Died of Off-Label Actiq Overdoses: A Kansas case in ... http://bit.ly/bqqGmA
Also Shared By:
McKesson to Administer Cephalon Programs for Cancer Pain | News & Analysis
beckershospitalreview.com — “Cephalon, a Woodlands, Texas, medical device company, has chosen McKesson Specialty Health to administer its FDA-approved FENTORA and ACIQ Risk Evaluation and Mitigation Strategy Programs for management breakthrough pain in cancer patients” View full resource at beckershospitalreview.com
Most Recently Shared on October 19, 2011 at 7:15 pm By:
RelayHealth Health Business and Health IT
McKesson to Administer Cephalon Programs for Cancer Pain | News & Analysis http://t.co/j3O4YWiz
q1productions.com » Blog Archive » Pharma Friday
q1productions.com — “q1productions.com » Blog Archive » Pharma Friday” View full resource at q1productions.com
Most Recently Shared on October 14, 2011 at 2:33 pm By:
Q1 Productions Health Business
Happy Friday, everyone! End the week right with Q1's #pharma Friday blog post: http://t.co/5DXS62XK #Teva #Cephalon #Rx
US Regulators Clear Teva Acquisition of Cephalon - Drugs.com MedNews
drugs.com — “From Associated Press (October 7, 2011) Generic drugmaker Teva Pharmaceutical Industries Ltd. said Friday the U.S. Federal Trade Commission has cleared its 6.8” View full resource at drugs.com
Most Recently Shared on October 10, 2011 at 5:09 pm By:
Drugs and Devices OW OW Health
US Regulators Clear Teva Acquisition of Cephalon: From Associated Press (October 7, 2011) Generic drugmake... http://t.co/GQvyJjKx #drug
FTC gives initial OK to Teva-Cephalon deal; divestiture required - Modern Healthcare
home.modernhealthcare.com — “FTC gives initial OK to Teva-Cephalon deal; divestiture required - Modern Healthcare” View full resource at home.modernhealthcare.com
Most Recently Shared on October 7, 2011 at 10:19 pm By:
Modern Healthcare: FTC gives initial OK to Teva-Cephalon deal; divestiture required http://j.mp/oEBNAn
FDA approves REMS for Fentora, Actiq | Oral Cancer News
oralcancernews.org — “FDA approves REMS for Fentora, Actiq | Oral Cancer News” View full resource at oralcancernews.org
Most Recently Shared on July 25, 2011 at 10:44 am By:
Scripintelligence - Cephalon shareholders approve acquisition by Teva
scripintelligence.com — “Cephalon shareholders have voted in favour of an offer by Teva Pharmaceutical Industries to buy the biotech for $81.50 per share in cash, or approximately $6.8 billion, and thus Teva is one step closer to a final deal. US and European regulators are still reviewing the deal. Last month, the US.” View full resource at scripintelligence.com
Most Recently Shared on July 18, 2011 at 12:55 pm By:
RT @scripnews: Cephalon shareholders approve acquisition by Teva: http://bit.ly/ppoOh4 #pharma
Feds probe Cephalon's Treanda marketing - FiercePharma
fiercepharma.com — “Yet another drugmaker finds itself under the U.S. Justice Department microscope. As Pharmalot reports, Cephalon ($CEPH) has received some requests from the feds for documents relating to potential Read more...” View full resource at fiercepharma.com
Most Recently Shared on July 12, 2011 at 4:35 pm By:
Feds probe Cephalon's Treanda marketing. http://bit.ly/qRmSvK
DDMAC issues untitled letter to Cephalon for Trisenox website - Medical Marketing and Media
mmm-online.com — “The FDA's Division of Drug Marketing, Advertising and Communications (DDMAC) issued an untitled letter to Cephalon, Inc. on June 21 after reviewing the company's HCP website for the injectible drug TRISENOX, indicated for the treatment of acute promyelocytic leukemia (APL).” View full resource at mmm-online.com
Most Recently Shared on June 28, 2011 at 7:58 pm By:
DDMAC issues untitled letter to Cephalon for Trisenox website: The FDA's Division of Drug Marketing, A... http://bit.ly/l3Vjun from MM&M
FDA To Cephalon: How Not To Build A Website // Pharmalot
pharmalot.com — “FDA To Cephalon: How Not To Build A Website // Pharmalot” View full resource at pharmalot.com
Most Recently Shared on June 28, 2011 at 1:02 pm By:
Scott Strumello Patient Expert
RT @ Pharmalot: FDA To Cephalon: How Not To Build A Website http://t.co/gCQAjLr
Teva's Cephalon acquisition could be delayed | InPharm
inpharm.com — “The Federal Trade Commission has requested more information about Teva’s deal with Cephalon, potentially delaying the purchase by a month” View full resource at inpharm.com
Most Recently Shared on June 15, 2011 at 8:57 am By:
Pharmafocus Pharma and Health News
Teva's Cephalon acquisition could be delayed http://goo.gl/fb/cgQoa
Cephalon CEO up for $14M severance in Teva deal - FiercePharma
fiercepharma.com — “Another pharma buyout, another set of golden parachutes. Now that Teva Pharmaceutical Industries has agreed to buy Cephalon for $6.8 billion, that company's top execs may be eligible for big payouts. Read more...” View full resource at fiercepharma.com
Most Recently Shared on June 3, 2011 at 2:50 pm By:
Cephalon CEO up for $14M severance in Teva deal. http://bit.ly/moYXOh
Cephalon Granted Temporary Restraining Order in AMRIX® Patent Litigation - Drugs.com MedNews
drugs.com — “Today, the United States District Court for the District of Delaware granted a motion filed by plaintiffs Cephalon, Inc. (NASDAQ CEPH), and Eurand, Inc., for a” View full resource at drugs.com
Most Recently Shared on May 21, 2011 at 1:03 am By:
Drugs and Devices OW OW Health
Cephalon Granted Temporary Restraining Order in AMRIX® Patent Litigation: FRAZER, Pa., May 20, 2011 /PRNew... http://bit.ly/mo75JJ #drug
Teva CFO: Cephalon price reasonable, even cheap - Globes
globes.co.il — “Teva CFO: Cephalon price reasonable, even cheap - Globes” View full resource at globes.co.il
Most Recently Shared on May 15, 2011 at 2:27 pm By:
Teva CFO: Cephalon price reasonable, even cheap: Eyal Desheh: I believe that Teva will continue to be the global... http://bit.ly/kxMdn1
UPDATE 1-Valeant looks past Cephalon for acquisitions | Reuters
reuters.com — “TORONTO, May 3 (Reuters) - Valeant Pharmaceuticals , which dropped a $5.7 billion offer for Cephalon Inc earlier this week, will actively pursue other largetakeover deals,” View full resource at reuters.com
Most Recently Shared on May 3, 2011 at 8:35 pm By:
John Carroll Health Communicator
Confident Valeant CEO Pearson says he's looking at a variety of takeover targets and can go bigger than cephalon. http://reut.rs/iGBYNq
Valeant moves on to new M&A targets - FiercePharma
fiercepharma.com — “Now that Teva Pharmaceutical Industries has snatched Cephalon, what's next for would-be suitor Valeant Pharmaceuticals? More deals, naturally. After all, Valeant CEO Michael Pearson said from the Read more...” View full resource at fiercepharma.com
Most Recently Shared on May 3, 2011 at 3:38 pm By:
Valeant moves on to new M&A targets. http://bit.ly/k1I01z
Advertisement
Jim Edwards
@Jim_Edwards
Cephalon's Lollipops of Death: 56 Patients at One Pain Clinic Died of Off-Label Actiq Overdoses: A Kansas case in ... http://bit.ly/bqqGmA
1 year ago...